Projects

Targeting DYRK1A: a key player in Down syndrome Leukaemogenesis

Development of new preclinical models of childhood leukaemia

Therapeutic opportunities from dissecting the pre-B leukaemia bone marrow microenvironment

Novel therapeutics approaches for infants with high-risk infant acute lymphoblastic leukaemia

Exploring clonal diversity in paediatric B-cell leukaemia to identify new therapeutic weakness